메뉴 건너뛰기
Journal of Neuropsychiatry and Clinical Neurosciences
Volumn 23, Issue 2, 2011, Pages
The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents
Author keywords

[No Author keywords available]
Indexed keywords

CLONAZEPAM; LAMOTRIGINE; PHENELZINE; RILUZOLE; TOPIRAMATE; AMINO ACID RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; DRUG DERIVATIVE; FRUCTOSE; MONOAMINE OXIDASE INHIBITOR; TRIAZINE DERIVATIVE;
EID: 85047689332     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/jnp.23.2.jnpe24     Document Type: Letter
Times cited : (6)
References (6)
  • 1
    • 85056063177 scopus 로고    scopus 로고
    • Glutamatergic synaptic dysfunction and obsessive-compulsive disorder
    • Ting JT, Feng G: Glutamatergic synaptic dysfunction and obsessive-compulsive disorder. Current Chemical Genomics 2008; 2:62-75
    • (2008) Current Chemical Genomics , vol.2 , pp. 62-75
    • Ting, J.T.1    Feng, G.2
  • 2
    • 24044522506 scopus 로고    scopus 로고
    • Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
    • Coric V, et al: Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry 2005; 58:424-428
    • (2005) Biol Psychiatry , vol.58 , pp. 424-428
    • Coric, V.1
  • 3
    • 38549171316 scopus 로고    scopus 로고
    • An open-label trial of riluzole, a glutamate antagonist, in children with treatment- resistant obsessive-compulsive disorder
    • Grant P, Lougee L, Hirschtritt M, et al: An open-label trial of riluzole, a glutamate antagonist, in children with treatment- resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2007; 17:761-767
    • (2007) J Child Adolesc Psychopharmacol , vol.17 , pp. 761-767
    • Grant, P.1    Lougee, L.2    Hirschtritt, M.3
  • 4
    • 50249184141 scopus 로고    scopus 로고
    • Does gabapentin lead to early symptom-improvement in obsessive-compulsive disorder?
    • Onder E, Tural U, Gokbakan M: Does gabapentin lead to early symptom-improvement in obsessive-compulsive disorder? Eur Arch Psychiatry Clin Neurosci 2008; 258:319-323
    • (2008) Eur Arch Psychiatry Clin Neurosci , vol.258 , pp. 319-323
    • Onder, E.1    Tural, U.2    Gokbakan, M.3
  • 5
    • 49549084326 scopus 로고    scopus 로고
    • Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: A series of 13 cases, with long-term follow-up
    • Pittenger C, et al: Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up. J Clin Psychopharmacol 2008; 28:363-367
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 363-367
    • Pittenger, C.1
  • 6
    • 33644502860 scopus 로고    scopus 로고
    • Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: A retrospective, openlabel case series
    • Van Ameringen M, Mancini C, Patterson B, et al: Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, openlabel case series. Depress Anx 2006; 23:1-5
    • (2006) Depress Anx , vol.23 , pp. 1-5
    • van Ameringen, M.1    Mancini, C.2    Patterson, B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.